Merck & Co., Inc. (MRK) Stock: Do Analysts Think You Should Buy?

Analysts who follow Merck & Co., Inc. (MRK) on average expect it to climb 27.21% over the next twelve months. Those same analysts give the stock an average rating of Buy. That average rating earns MRK an Analyst Ranking of 29, which means it ranks higher than 29 of stocks, based on data compiled by InvestorsObserver.

Wall Street analysts are rating MRK a Buy today. Find out what this means to you and get the rest of the rankings on MRK!

See Full MRK Report

Why are Analyst Ratings Important?

Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions **before** a quarterly report that could be worse than expected. InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.

What's Happening With Merck & Co., Inc. Stock Today?

Merck & Co., Inc. (MRK) stock is trading at $73.65 as of 1:37 PM on Monday, Dec 6, an increase of $0.31, or 0.42% from the previous closing price of $73.34. Volume today is light. So far 7,077,853 shares have traded compared to average volume of 14,983,959 shares. The stock has traded between $72.80 and $73.85 so far today. Click Here to get the full Stock Report for Merck & Co., Inc. stock.